| Literature DB >> 29945010 |
Robert Fahed1, Tim E Darsaut2, Jean Raymond3.
Abstract
Most neurovascular innovations have been introduced by using case series followed by observational studies. A better approach would be a pragmatic randomized trial. Two important aspects of trial design, patient selection and randomized allocation, remain poorly understood. We discuss the role trial methodology can play in the protection of patients being offered innovative treatments. Published by Elsevier Inc.Entities:
Keywords: Device; Ethics; Flow Diverter; Methodology
Mesh：
Year: 2018 PMID： 29945010 DOI： 10.1016/j.wneu.2018.06.127
Source DB: PubMed Journal: World Neurosurg ISSN： 1878-8750 Impact factor: 2.104